# EyePoint Pharmaceuticals, Inc. – FDA Inspection, Aug 28, 2019

Source: https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/bd40ecfd-6d7a-4c39-8319-1d042041f48b
Source feed: FDA_Inspections

> FDA inspection 1102130 of EyePoint Pharmaceuticals, Inc., August 28, 2019. Classification: Official Action Indicated (OAI). 9 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102130
- Company Name: EyePoint Pharmaceuticals, Inc.
- Inspection Date: 2019-08-28
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 9

## Related Documents

- [FDA Inspection 1230113 - 2024-02-15](https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/96011f71-7dc7-4d1e-af2a-8fb571d5f403)
- [FDA Inspection 1150669 - 2021-09-01](https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/bc7824a1-722e-4a03-8af8-91a2affaaa96)
- FDA Inspection 1067552 - 2018-09-19
- [FDA Inspection 1046783 - 2018-04-04](https://www.keypedia.com/records/fda_inspections/eyepoint-pharmaceuticals-inc/0db9fefd-9ce7-4f02-8336-60414449746e)

## Related Officers

- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)

Company: https://www.keypedia.com/companies/eyepoint-pharmaceuticals-inc/ca6562a2-b315-4e33-b9b2-394c1c8ad945

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
